Table 1: Publications decrying the resistance of thromboembolic disease to medical intervention.
Inadequacy of osocimab and apixaban for prevention of post-surgical thromboembolic complications [12]. |
Inadequacy of standard aspirin doses, low molecular heparin and factor Xa inhibitor in preventing or resolving post-surgical thrombotic events [13,14]. |
Inadequacy of low molecular heparin and factor Xa inhibitor in preventing hemophilia-induced tissue damage [15]. |
Inadequacy of low molecular heparin and factor Xa inhibitor in preventing space-flight related thrombotic events [16]. |
Inadequacy of traditional low dose aspirin in preventing thromboembolic disease [17]. |
Inadequacy of standard anticoagulation doses to prevent thromboembolic disease in high risk patients [18]. |